Back to Search
Start Over
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
- Source :
-
Journal of virology [J Virol] 1999 Apr; Vol. 73 (4), pp. 3292-300. - Publication Year :
- 1999
-
Abstract
- The kinetics of T-helper immune responses generated in 16 mature outbred rhesus monkeys (Macaca mulatta) within a 10-month period by three different human immunodeficiency virus type 1 (HIV-1) vaccine strategies were compared. Immune responses to monomeric recombinant gp120SF2 (rgp120) when the protein was expressed in vivo by DNA immunization or when it was delivered as a subunit protein vaccine formulated either with the MF59 adjuvant or by incorporation into immune-stimulating complexes (ISCOMs) were compared. Virus-neutralizing antibodies (NA) against HIV-1SF2 reached similar titers in the two rgp120SF2 protein-immunized groups, but the responses showed different kinetics, while NA were delayed and their levels were low in the DNA-immunized animals. Antigen-specific gamma interferon (IFN-gamma) T-helper (type 1-like) responses were detected in the DNA-immunized group, but only after the fourth immunization, and the rgp120/MF59 group generated both IFN-gamma and interleukin-4 (IL-4) (type 2-like) responses that appeared after the third immunization. In contrast, rgp120/ISCOM-immunized animals rapidly developed marked IL-2, IFN-gamma (type 1-like), and IL-4 responses that peaked after the second immunization. To determine which type of immune responses correlated with protection from infection, all animals were challenged intravenously with 50 50% infective doses of a rhesus cell-propagated, in vivo-titrated stock of a chimeric simian immunodeficiency virus-HIVSF13 construct. Protection was observed in the two groups receiving the rgp120 subunit vaccines. Half of the animals in the ISCOM group were completely protected from infection. In other subunit vaccinees there was evidence by multiple assays that virus detected at 2 weeks postchallenge was effectively cleared. Early induction of potent type 1- as well as type 2-like T-helper responses induced the most-effective immunity.
- Subjects :
- AIDS Vaccines chemistry
AIDS Vaccines pharmacology
Acquired Immunodeficiency Syndrome prevention & control
Adjuvants, Immunologic pharmacology
Animals
Chemistry, Pharmaceutical
HIV Envelope Protein gp120 pharmacology
Humans
ISCOMs pharmacology
Macaca mulatta
Recombinant Proteins immunology
Recombinant Proteins pharmacology
AIDS Vaccines immunology
Acquired Immunodeficiency Syndrome immunology
HIV Envelope Protein gp120 immunology
HIV-1 immunology
ISCOMs immunology
Immunity, Cellular
Polysorbates pharmacology
Squalene immunology
Squalene pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0022-538X
- Volume :
- 73
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of virology
- Publication Type :
- Academic Journal
- Accession number :
- 10074183
- Full Text :
- https://doi.org/10.1128/JVI.73.4.3292-3300.1999